Genentech announces new project in Wake County, expected to create 400 jobs
Yesterday, San Francisco-based Genentech, a premier biotech leader, announced plans for a new Wake County project. The new project will support Roche and Genentech’s future portfolio of next-generation obesity medicines. Roche and Genentech currently operate 13 manufacturing and 15 research and development sites, employing over 25,000 people in eight different states. This project represents the company’s first East Coast manufacturing facility.
Key Metrics for the new project:
The company plans to create over 400 jobs, and over 1,500 short-term construction jobs.
The new facility will be over 700,000 square feet and located in Holly Springs.
The company plans to invest over $700 million and support an average salary of $119,833.
What they are saying:
Genentech CEO Asheley Magargee said: “Our new facility near Raleigh, North Carolina, an established biopharmaceutical talent hub, will serve as an important new setting within our manufacturing network to help deliver on the promise of our company’s life-changing science and industry-leading pipeline. We are thrilled to establish this relationship with the city of Holly Springs, where we expect to have a positive impact on the local economy and community, as we have across the United States since we pioneered the biotech industry nearly 50 years ago.”
U.S. Senator Thom Tillis said, “Genentech's investment in North Carolina marks a significant milestone for our state's biotechnology sector. I congratulate Genentech on their commitment to fostering innovation and creating high-quality jobs for our residents.”
Governor Josh Stein said, “I’m proud that Genentech has chosen North Carolina for its first facility on the East Coast. This major investment in Holly Springs shows that our state continues to be a leading destination for life sciences and advanced manufacturing. With more than 400 new jobs on the way, this project will strengthen our economy, create opportunities for our people, and advance cutting-edge scientific innovation right here in North Carolina.”
